Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
public health
Biotech
At ESMO, oncologists reflect on the global dominance of GLP-1s
If you’ve been living under a rock, you still know about GLP-1s. 33,000 ESMO attendees would like to remind you that cancer research is exciting too.
Annalee Armstrong
Nov 1, 2023 9:52am
J&J ends R&D at Janssen's infectious disease and vaccine unit
Aug 23, 2023 11:32am
Color triples valuation with $100M funding boost
Nov 10, 2021 10:10am
Hahn heads toward FDA exit after short, dramatic tenure
Dec 22, 2020 7:00am
J&J, BARDA pick 7 startups to back in fight against COVID-19
Aug 27, 2020 7:00am
The question of who pays for COVID-19 tests
Jul 21, 2020 9:50am
